Genetics, longevity and mycology, read carefully.
Your genome is a lifelong document, and the science that reads it keeps moving. We write down what the evidence supports, and what it does not yet.

darkMatter is a biotech company working on the damage that ages us.
We develop our own technology, back founders building theirs, and publish what the science supports.
Long reads on the
science we build on
Why I talk to my geneticist
I've had my genome read twice: a chip test and true whole-genome sequencing. Neither taught me anything about myself. What did was a person.
What your family history already knows
The oldest genetic test is a set of questions about your relatives. Asked properly, they read things no sequencer can.
8 min readThe first genome we ever read was a fungus
Much of what we know about cellular ageing was observed in yeast decades before anyone went looking for it in us.
4 min readThe Evidence-Based Longevity Playbook
Evidence-based strategies associated with longer survival and healthier aging.
11 min readAging as a glass
The body does not wear out so much as seize up. One idea, four places it shows up, and the measurement that would prove it wrong.
8 min readWhat happened to resveratrol
A Nature paper, a $720 million acquisition, a contested mechanism, and capsules still on the shelf. The clearest lesson in how to read a longevity claim.
5 min readThree subjects, one question underneath
What your genome actually says
Risk scores, rare variants, inheritance. A result places you in a population; it does not predict your life.
What holds up over decades
Interventions, biomarkers and evidence quality: what decades of follow-up support, and what is still only plausible.
The kingdom we keep underestimating
Fungal genomes, symbiosis and metabolism: where much of what we know about cellular ageing was first observed.
How does reading a whole genome work?
How a whole genome actually gets read, explained plainly. It is the science we keep returning to.
01A cheek swab
Cells from inside the cheek carry the same complete instruction set as every other cell. Thirty seconds is enough.
02Read at 30× depth
Each position is read about thirty independent times. That redundancy is what separates a real variant from an error.
03Interpreted
Six billion letters become a few million differences from the reference, then the few hundred anyone currently knows how to act on.
04Read again later
The sequence does not change; its meaning does. Re-interpretation is the part that makes one sample worth keeping.
Read each piece first
Leave your address and every new piece reaches you the day it publishes. That is the whole of it: no fees, no gate, no selling.
darkMatter acquired the management and general partner of the MarsBio Fund in 2025 and now manages a portfolio of 13 companies building at the frontier of biology.
Fair questions, answered straight
Including the one about whether you can buy anything yet.
Not today, but we are working on technology that will radically change the cost structure of genome sequencing. Follow our journey and learn with us along the way.
Reading all of your DNA rather than a selected subset. A chip-based test genotypes a few hundred thousand positions chosen in advance; sequencing reads the whole text, which means new questions can be asked of the same data later without a new sample.
Each position is read about thirty independent times. That redundancy is what makes a single-letter difference trustworthy: a sequencing error shows up in one read, a real variant shows up in all of them.
Because fungi solved a chemistry problem our cells cannot. Over decades, tissue accumulates crosslinks that no human enzyme can break, and the network they hold together stiffens into something close to glass. Fungi are the only organisms that learned to cut bonds like these: when lignin appeared 300 million years ago, nothing on Earth could break it down until white-rot fungi evolved the enzymes to do it. Yeast also gave us much of the early work on cellular ageing. darkMatter’s thesis on aging starts from that record.
For most conditions, no. It tells you where you sit relative to others, which is most useful when it changes a decision — when to start screening, whether a borderline treatment is worth it. We will keep saying that even when it is less exciting than the alternative.

It always starts with you.
Six billion letters, already written. We are learning to read them properly, and publishing as we go.